These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Secondary prevention of pneumocystis carinii pneumonia by intravenous pentamidine]. García Aguado C; Martínez ML; Díaz F; González Lahoz JM Med Clin (Barc); 1990 Jun; 95(5):197-8. PubMed ID: 2214912 [No Abstract] [Full Text] [Related]
47. Severe neutropenia during pentamidine treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome--New York City. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1984 Feb; 33(6):65-7. PubMed ID: 6422241 [No Abstract] [Full Text] [Related]
48. [A case from practice (124). Patient: Mr. B. S., born 1949, buyer]. Suter D Schweiz Rundsch Med Prax; 1988 Dec; 77(51):1413-5. PubMed ID: 3265531 [No Abstract] [Full Text] [Related]
49. Cardiovascular effects and safety of intravenous and intramuscular pentamidine isethionate. Mallory DL; Parrillo JE; Bailey KR; Akin GL; Brenner M; Lane HC; Fauci AS; Masur H Crit Care Med; 1987 May; 15(5):503-5. PubMed ID: 3494569 [TBL] [Abstract][Full Text] [Related]
50. Pentamidine isethionate. A review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia. Goa KL; Campoli-Richards DM Drugs; 1987 Mar; 33(3):242-58. PubMed ID: 3552596 [TBL] [Abstract][Full Text] [Related]
52. Changes in taste associated with intravenous administration of pentamidine (revised). Glover J; Dibble S; Miaskowski C; Geibert R J Assoc Nurses AIDS Care; 1995; 6(2):41-6. PubMed ID: 7599331 [TBL] [Abstract][Full Text] [Related]
53. FDA approves wider use of aerosolized pentamidine to prevent pneumocystis pneumonia. Oncology (Williston Park); 1989 Mar; 3(3):54. PubMed ID: 2641319 [No Abstract] [Full Text] [Related]
54. Pentamidine aerosol to prevent Pneumocystis carinii pneumonia. Med Lett Drugs Ther; 1989 Oct; 31(802):91-2. PubMed ID: 2571064 [No Abstract] [Full Text] [Related]
55. Reversal of pentamidine-induced hypoglycaemia with oral diazoxide. Fitzgerald DB; Young IS J Trop Med Hyg; 1984 Feb; 87(1):15-9. PubMed ID: 6371261 [TBL] [Abstract][Full Text] [Related]
56. Torsade de pointes during administration of pentamidine isethionate. Wharton JM; Demopulos PA; Goldschlager N Am J Med; 1987 Sep; 83(3):571-6. PubMed ID: 3499072 [TBL] [Abstract][Full Text] [Related]
57. Toxic epidermal necrolysis caused by aerosolized pentamidine. Watarai A; Niiyama S; Amoh Y; Katsuoka K Am J Med; 2009 Jan; 122(1):e1-2. PubMed ID: 19114157 [No Abstract] [Full Text] [Related]
58. Pentamidine for the treatment of Pneumocystis carinii pneumonia and other protozoal diseases. Pearson RD; Hewlett EL Ann Intern Med; 1985 Nov; 103(5):782-6. PubMed ID: 3901852 [TBL] [Abstract][Full Text] [Related]
59. Pancreatitis during intravenous pentamidine therapy in an AIDS patient with prior exposure to didanosine. Foisy MM; Slayter KL; Hewitt RG; Morse GD Ann Pharmacother; 1994 Sep; 28(9):1025-8. PubMed ID: 7803875 [TBL] [Abstract][Full Text] [Related]
60. Pentamidine-induced torsades de pointes in a renal transplant recipient with Pneumocystis carinii pneumonia. Green PT; Reents S; Harman E; Curtis AB South Med J; 1990 Apr; 83(4):481-4. PubMed ID: 2321077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]